Allianz Asset Management’s BioLife Solutions BLFS Stock Holding History

Allianz Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-91,501	Closed	-$869K	–	2395
2020 Q1	$869K	Sell	91,501 -260	-0.3%	-$3.57K	﹤0.01%	1851
2019 Q4	$1.49M	Buy	91,761 +4,600	+5%	+$74.8K	﹤0.01%	2016
2019 Q3	$1.45M	Sell	87,161 -128,288	-60%	-$2.41M	﹤0.01%	1964
2019 Q2	$3.65M	Buy	215,449 +14,779	+7%	+$258K	﹤0.01%	1650
2019 Q1	$3.59M	Buy	+200,670	New	+$3.19M	﹤0.01%	1606

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SPA

Sentinel Pension Advisors Wakefield, Massachusetts $676M AUM 15.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return

Allianz Asset Management's BLFS Position: Q2 2020 in Review

Allianz Asset Management sold out of BioLife Solutions (BLFS) in Q2 2020, closing a stake of 91,501 shares — an estimated $869K sold.

Allianz Asset Management first reported a position in BLFS in Q1 2019 and held it in 5 quarters. The position peaked at $3.65M in Q2 2019. 82 funds tracked by Wall St. Rank hold BLFS as of Q2 2020.

Allianz Asset Management reported no remaining BioLife Solutions position as of Q2 2020 after selling out during the quarter.
Allianz Asset Management sold 91,501 BioLife Solutions shares in Q2 2020, an estimated $869K.
Allianz Asset Management first reported a position in BioLife Solutions in Q1 2019 and held it in 5 quarters.
Allianz Asset Management's BioLife Solutions position peaked at $3.65M in Q2 2019.
82 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.